November 21, 2003. It is clear that both women and men alike continue to search for the fountain of youth. We know that these products are widely used, and that’s why they should be carefully studied. They should be approved if they are safe and effective.
Read More »Author: NCHR Author
Testimony at FDA on Silicone Gel Breast Implants
October 15, 2003. The FDA’s study, described by Dr. Lori Brown yesterday, is the best designed study ever conducted on the topic. One reason for its superiority is that it focused on women who were basically happy with their implants, and who had implants for at least 7 years.
Read More »Comment On Medwatch: The FDA Medical Products Reporting Program
April 23, 2003. Rather than weaken or dismantling the MedWatch system, the FDA should borrow ideas from more rigorous systems in other countries. The FDA should provide ongoing education and incentives for quality reporting by both health professionals and consumers.
Read More »Comment On Dietary Supplements Containing Ephedrine
April 23, 2003. At this time, there is little evidence suggesting that ephedra is effective for weight loss, unless used in conjunction with strategies that are effective without ephedra.
Read More »Comment on FDA Guidance For Industry Collection of Race and Ethnicity Data in Clinical Trials
March 25, 2003. It is the policy of the National Institute of Health that women and members of minority groups must be included in all NIH supported biomedical and behavioral research projects.
Read More »